Video Experimental Relacionado
Updated: Jun 11, 2026
09:04
Recording Gamma Band Oscillations in Pedunculopontine Nucleus Neurons
Published on: September 14, 2016
Síntesis total de (-) -scabronina G, un inductor de la producción del factor neurotrófico
Stephen P Waters1, Yuan Tian, Yue-Ming Li
1Laboratory for Bioorganic Chemistry and Laboratory of Biochemistry and Pharmacology, Sloan-Kettering Institute for Cancer Research, New York, New York 10021, USA.
Journal of the American Chemical Society
|September 30, 2005
Resumen
Se logró la síntesis total de scabronina G. Este compuesto y su éster metílico muestran potencial como inductores no peptídicos de la producción del factor de crecimiento nervioso.
Área de la Ciencia:
- Química orgánica es la química orgánica.
- La neurociencia es la neurociencia.
- Química Medicinal La Química Medicinal es el campo de la Química Medicinal.
Sus antecedentes:
- La scabronina G es un producto natural con actividad biológica potencial.
- El desarrollo de rutas sintéticas eficientes para moléculas complejas es crucial para un estudio posterior.
- El factor de crecimiento nervioso (NGF) juega un papel vital en el desarrollo neuronal y la supervivencia.
Objetivo del estudio:
- Para lograr la síntesis total de (-) -scabronina G.
- Para preparar el más potente derivado del éster metílico de scabronine G.
- Evaluar la actividad biológica de la scabronina G y su éster como inductores de la producción del factor de crecimiento nervioso.
Principales métodos:
- Utilizó el (-) - Wieland-Miescher cetona como material de partida.
- Empleó una estrategia sintética concisa para la molécula objetivo.
- Caracterizó los compuestos sintetizados utilizando técnicas analíticas estándar.
Principales resultados:
- Se ha sintetizado con éxito (-) -scabronina G.
- Sintetizó el éster metílico de la scabronina G.
- Se demostró que ambos compuestos actúan como inductores no peptídicos de la producción del factor de crecimiento nervioso.
Conclusiones:
- La síntesis total de (-) -scabronina G es factible a través de una ruta concisa.
- La scabronina G y su éster metílico representan una nueva clase de inductores de NGF no peptídico.
- Estos hallazgos abren caminos para el desarrollo de nuevas terapias dirigidas a la salud neuronal.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...